Microplate fluorescence protease assays test the inhibition of select North American snake venoms' activities with an anti-proteinase library

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Snake envenomation is a relatively neglected significant world health problem, designated an orphan disease by the WHO. While often effective, antivenins are insufficient. Could another approach greatly aid inhibition of the venom toxins? New fluorescent substrates for measuring protease activity in microplate assays suitable for high throughput screening were tested and found reproducible with snake venom. Representative North American venoms showed relatively strong proteinase and collagenase, but weaker elastase activities. Caseinolytic activity is inhibited by the nonspecific proteinase inhibitor 1,10-phenanthroline and by EDTA, as is collagenase activity, consistent with the action of metalloproteinases. Both general protease and collagenase assays CV average 3%, and Km measured were above normal working conditions. Using a library of anti -proteinase compounds with multiple venoms revealed high inhibitor activity by three agents with known multiple metalloproteinase inhibitor activity (Actinonin, GM6001, and NNGH), which incidentally supports the concept that much of the degradative activity of certain venoms is due to metalloproteinases with collagenase activity. These results together support the use of microplate proteinase assays, particularly this collagenase assay, in future drug repurposing studies leading to the development of new treatments for those envenomations that have a major proteolytic component in their pathophysiology.

Original languageEnglish
Pages (from-to)145-154
Number of pages10
JournalToxicon
Volume103
DOIs
StatePublished - 13 Jul 2015

Fingerprint

Snake Venoms
Collagenases
Assays
Peptide Hydrolases
Fluorescence
Venoms
Metalloproteases
Drug Repositioning
High-Throughput Screening Assays
Antivenins
Snake Bites
Pancreatic Elastase
Medical problems
Rare Diseases
Edetic Acid
Libraries
Screening
Throughput
Substrates
Pharmaceutical Preparations

Keywords

  • Collagenase
  • Inhibitors
  • Metalloproteinase
  • Protease
  • Venom

Cite this

@article{a1ccb76b989b4cc18e54de0182eeb06e,
title = "Microplate fluorescence protease assays test the inhibition of select North American snake venoms' activities with an anti-proteinase library",
abstract = "Snake envenomation is a relatively neglected significant world health problem, designated an orphan disease by the WHO. While often effective, antivenins are insufficient. Could another approach greatly aid inhibition of the venom toxins? New fluorescent substrates for measuring protease activity in microplate assays suitable for high throughput screening were tested and found reproducible with snake venom. Representative North American venoms showed relatively strong proteinase and collagenase, but weaker elastase activities. Caseinolytic activity is inhibited by the nonspecific proteinase inhibitor 1,10-phenanthroline and by EDTA, as is collagenase activity, consistent with the action of metalloproteinases. Both general protease and collagenase assays CV average 3{\%}, and Km measured were above normal working conditions. Using a library of anti -proteinase compounds with multiple venoms revealed high inhibitor activity by three agents with known multiple metalloproteinase inhibitor activity (Actinonin, GM6001, and NNGH), which incidentally supports the concept that much of the degradative activity of certain venoms is due to metalloproteinases with collagenase activity. These results together support the use of microplate proteinase assays, particularly this collagenase assay, in future drug repurposing studies leading to the development of new treatments for those envenomations that have a major proteolytic component in their pathophysiology.",
keywords = "Collagenase, Inhibitors, Metalloproteinase, Protease, Venom",
author = "Joseph Price",
year = "2015",
month = "7",
day = "13",
doi = "10.1016/j.toxicon.2015.06.020",
language = "English",
volume = "103",
pages = "145--154",
journal = "Toxicon",
issn = "0041-0101",
publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Microplate fluorescence protease assays test the inhibition of select North American snake venoms' activities with an anti-proteinase library

AU - Price, Joseph

PY - 2015/7/13

Y1 - 2015/7/13

N2 - Snake envenomation is a relatively neglected significant world health problem, designated an orphan disease by the WHO. While often effective, antivenins are insufficient. Could another approach greatly aid inhibition of the venom toxins? New fluorescent substrates for measuring protease activity in microplate assays suitable for high throughput screening were tested and found reproducible with snake venom. Representative North American venoms showed relatively strong proteinase and collagenase, but weaker elastase activities. Caseinolytic activity is inhibited by the nonspecific proteinase inhibitor 1,10-phenanthroline and by EDTA, as is collagenase activity, consistent with the action of metalloproteinases. Both general protease and collagenase assays CV average 3%, and Km measured were above normal working conditions. Using a library of anti -proteinase compounds with multiple venoms revealed high inhibitor activity by three agents with known multiple metalloproteinase inhibitor activity (Actinonin, GM6001, and NNGH), which incidentally supports the concept that much of the degradative activity of certain venoms is due to metalloproteinases with collagenase activity. These results together support the use of microplate proteinase assays, particularly this collagenase assay, in future drug repurposing studies leading to the development of new treatments for those envenomations that have a major proteolytic component in their pathophysiology.

AB - Snake envenomation is a relatively neglected significant world health problem, designated an orphan disease by the WHO. While often effective, antivenins are insufficient. Could another approach greatly aid inhibition of the venom toxins? New fluorescent substrates for measuring protease activity in microplate assays suitable for high throughput screening were tested and found reproducible with snake venom. Representative North American venoms showed relatively strong proteinase and collagenase, but weaker elastase activities. Caseinolytic activity is inhibited by the nonspecific proteinase inhibitor 1,10-phenanthroline and by EDTA, as is collagenase activity, consistent with the action of metalloproteinases. Both general protease and collagenase assays CV average 3%, and Km measured were above normal working conditions. Using a library of anti -proteinase compounds with multiple venoms revealed high inhibitor activity by three agents with known multiple metalloproteinase inhibitor activity (Actinonin, GM6001, and NNGH), which incidentally supports the concept that much of the degradative activity of certain venoms is due to metalloproteinases with collagenase activity. These results together support the use of microplate proteinase assays, particularly this collagenase assay, in future drug repurposing studies leading to the development of new treatments for those envenomations that have a major proteolytic component in their pathophysiology.

KW - Collagenase

KW - Inhibitors

KW - Metalloproteinase

KW - Protease

KW - Venom

UR - http://www.scopus.com/inward/record.url?scp=84937035575&partnerID=8YFLogxK

U2 - 10.1016/j.toxicon.2015.06.020

DO - 10.1016/j.toxicon.2015.06.020

M3 - Article

C2 - 26130521

AN - SCOPUS:84937035575

VL - 103

SP - 145

EP - 154

JO - Toxicon

JF - Toxicon

SN - 0041-0101

ER -